Literature DB >> 8340677

Inherited deficiencies of the terminal complement components.

F Tedesco1, W Nürnberger, S Perissutti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8340677     DOI： 10.3109/08830189309051171

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN： 0883-0185            Impact factor:   5.311


× No keyword cloud information.
  7 in total

1.  Meningococcal meningitis in a patient with urticarial vasculitis: is there a link?

Authors:  Hana Alachkar; Faieza Qasim; Yasmeen Ahmad; Matthew Helbert
Journal:  J Clin Pathol       Date:  2007-10       Impact factor: 3.411

2.  Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.

Authors:  C Franco-Jarava; D Comas; A Orren; M Hernández-González; R Colobran
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

3.  Investigation for complement deficiency following meningococcal disease.

Authors:  S Hoare; O El-Shazali; J E Clark; A Fay; A J Cant
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

4.  The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro.

Authors:  R Rampersad; A Barton; Y Sadovsky; D M Nelson
Journal:  Placenta       Date:  2008-09-09       Impact factor: 3.481

5.  The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.

Authors:  F Tedesco; M Pausa; E Nardon; M Introna; A Mantovani; A Dobrina
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

6.  Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.

Authors:  Carine El Sissy; Jérémie Rosain; Paula Vieira-Martins; Pauline Bordereau; Aurélia Gruber; Magali Devriese; Loïc de Pontual; Muhamed-Kheir Taha; Claire Fieschi; Capucine Picard; Véronique Frémeaux-Bacchi
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

7.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.